Precision Medicine

Transforming medical and surgical care for pediatric patients with relapsed and refractory cancers through deep profiling to identify novel cell therapy targets and integration of CHOP’s precision medicine and cellular therapy programs.

The Campbell Lab strives to develop approaches to genetic diagnosis so that every child with a genetic disease is diagnosed as quickly and accurately as possible. By harnessing the CHOP electronic health record, the lab uses state-of-the art techniques to define and diagnose genetic diseases.

Providing personalized treatment strategies, using comprehensive multi-omic tumor profiling, to define the best individual treatment options. This includes clinical trials for patients who lack effective standard of care treatments, or who have relapsed or refractory cancers.